| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid hormone binding | 1.39e-04 | 7 | 52 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 2.95e-04 | 10 | 52 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 2.95e-04 | 10 | 52 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 3.60e-04 | 11 | 52 | 2 | GO:0008556 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PNPLA6 PIK3C2B MTHFD1 NT5C3A ENTPD1 PIPOX RBKS PLCG1 IDH2 INPP5F MDH2 LDHC | 2.06e-05 | 1142 | 52 | 12 | GO:0019637 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 2.95e-05 | 24 | 52 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 3.73e-05 | 4 | 52 | 2 | GO:0031161 | |
| GeneOntologyBiologicalProcess | response to glycoside | 6.20e-05 | 5 | 52 | 2 | GO:1903416 | |
| GeneOntologyBiologicalProcess | glycerophospholipid catabolic process | 1.11e-04 | 37 | 52 | 3 | GO:0046475 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 3.63e-05 | 4 | 52 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 3.94e-04 | 12 | 52 | 2 | GO:0005890 | |
| MousePheno | abnormal muscle contractility | 2.89e-05 | 418 | 42 | 8 | MP:0005620 | |
| Domain | P-type_ATPase_IIC | 1.05e-04 | 6 | 50 | 2 | IPR005775 | |
| Domain | L-lactate/malate_DH | 1.95e-04 | 8 | 50 | 2 | IPR001557 | |
| Domain | Ldh_1_N | 1.95e-04 | 8 | 50 | 2 | PF00056 | |
| Domain | Lactate/malate_DH_N | 1.95e-04 | 8 | 50 | 2 | IPR001236 | |
| Domain | - | 2.50e-04 | 9 | 50 | 2 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 2.50e-04 | 9 | 50 | 2 | IPR022383 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 2.50e-04 | 9 | 50 | 2 | IPR015955 | |
| Domain | Ldh_1_C | 2.50e-04 | 9 | 50 | 2 | PF02866 | |
| Domain | WAP | 8.23e-04 | 16 | 50 | 2 | SM00217 | |
| Domain | - | 8.23e-04 | 16 | 50 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 8.23e-04 | 16 | 50 | 2 | IPR023298 | |
| Domain | WAP | 8.23e-04 | 16 | 50 | 2 | PF00095 | |
| Domain | ATPase_P-typ_cation-transptr_C | 9.31e-04 | 17 | 50 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 9.31e-04 | 17 | 50 | 2 | PF00689 | |
| Domain | WAP | 9.31e-04 | 17 | 50 | 2 | PS51390 | |
| Domain | - | 9.31e-04 | 17 | 50 | 2 | 4.10.75.10 | |
| Domain | Cation_ATPase_N | 1.05e-03 | 18 | 50 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 1.05e-03 | 18 | 50 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.17e-03 | 19 | 50 | 2 | IPR004014 | |
| Domain | HAD-like_dom | 1.24e-03 | 79 | 50 | 3 | IPR023214 | |
| Domain | WAP_dom | 1.57e-03 | 22 | 50 | 2 | IPR008197 | |
| Domain | - | 3.31e-03 | 32 | 50 | 2 | 3.40.1110.10 | |
| Domain | - | 3.31e-03 | 32 | 50 | 2 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.95e-03 | 35 | 50 | 2 | IPR023299 | |
| Domain | P_typ_ATPase | 4.18e-03 | 36 | 50 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.18e-03 | 36 | 50 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.18e-03 | 36 | 50 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.41e-03 | 37 | 50 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.41e-03 | 37 | 50 | 2 | PF00122 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 8.00e-09 | 175 | 52 | 7 | 25756610 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EEF2 UBR5 MTHFD1 DNAJA2 NCAPD2 HAT1 IDH2 HARS1 ATP1A1 MDH2 HNRNPK SOD1 | 9.72e-08 | 1149 | 52 | 12 | 35446349 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 3.23e-07 | 621 | 52 | 9 | 22794259 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 5.04e-07 | 104 | 52 | 5 | 36055981 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EEF2 MTHFD1 DNAJA2 NCAPD2 HAT1 POGZ PLCG1 IDH2 HARS1 ATP1A1 MDH2 HNRNPK | 9.64e-07 | 1425 | 52 | 12 | 30948266 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 9.81e-07 | 221 | 52 | 6 | 29991511 | |
| Pubmed | EEF2 PNPLA6 ZC2HC1A MTHFD1 DNAJA2 EIF2S3B IDH2 ATP1A1 ATP1A3 MDH2 HNRNPK SOD1 | 1.01e-06 | 1431 | 52 | 12 | 37142655 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21498719 | ||
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 2.19e-06 | 2 | 52 | 2 | 11546672 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 24391932 | ||
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 2.19e-06 | 2 | 52 | 2 | 23761886 | |
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 2.19e-06 | 2 | 52 | 2 | 3030810 | |
| Pubmed | 2.70e-06 | 803 | 52 | 9 | 36517590 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.81e-06 | 807 | 52 | 9 | 30575818 | |
| Pubmed | K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. | 2.81e-06 | 65 | 52 | 4 | 29378950 | |
| Pubmed | 3.19e-06 | 271 | 52 | 6 | 26816005 | ||
| Pubmed | Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis. | 4.11e-06 | 21 | 52 | 3 | 30179224 | |
| Pubmed | Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. | 4.22e-06 | 160 | 52 | 5 | 23798571 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 4.44e-06 | 287 | 52 | 6 | 36180891 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 2822726 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 6.57e-06 | 3 | 52 | 2 | 30819023 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 23629676 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 27836549 | ||
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 6.57e-06 | 3 | 52 | 2 | 26373354 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 17947306 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 19058785 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 28465228 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 31430754 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 8203495 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 31098770 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 35995176 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18044013 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 26988030 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 26911348 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25994790 | ||
| Pubmed | 7.95e-06 | 488 | 52 | 7 | 31324722 | ||
| Pubmed | 9.02e-06 | 87 | 52 | 4 | 24169447 | ||
| Pubmed | 1.01e-05 | 28 | 52 | 3 | 30947518 | ||
| Pubmed | 1.13e-05 | 92 | 52 | 4 | 20301317 | ||
| Pubmed | 1.16e-05 | 197 | 52 | 5 | 31620119 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.23e-05 | 732 | 52 | 8 | 34732716 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.24e-05 | 344 | 52 | 6 | 36282215 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.24e-05 | 344 | 52 | 6 | 30333137 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 1.25e-05 | 200 | 52 | 5 | 35546148 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 21731499 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 12458206 | ||
| Pubmed | A mouse homologue of Strawberry Notch is transcriptionally regulated by Reelin signal. | 1.31e-05 | 4 | 52 | 2 | 17045962 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 21849490 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 17446412 | ||
| Pubmed | Na,K-ATPase expression in the mouse cochlea is not dependent on the mineralocorticoid receptor. | 1.31e-05 | 4 | 52 | 2 | 11591489 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 19751721 | ||
| Pubmed | Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. | 1.31e-05 | 4 | 52 | 2 | 19376779 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 17234593 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 2887455 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.53e-05 | 357 | 52 | 6 | 37059091 | |
| Pubmed | 2.04e-05 | 565 | 52 | 7 | 20458337 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 2.04e-05 | 565 | 52 | 7 | 33567341 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 2.19e-05 | 5 | 52 | 2 | 3035563 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.50e-05 | 583 | 52 | 7 | 29844126 | |
| Pubmed | 2.63e-05 | 114 | 52 | 4 | 28245920 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EEF2 PNPLA6 ZC2HC1A UBR5 MTHFD1 DNAJA2 NCAPD2 POGZ PLCG1 HNRNPK | 2.74e-05 | 1353 | 52 | 10 | 29467282 |
| Pubmed | 2.78e-05 | 397 | 52 | 6 | 21319273 | ||
| Pubmed | 2.82e-05 | 237 | 52 | 5 | 29564676 | ||
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 3.21e-05 | 120 | 52 | 4 | 37929963 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 3036582 | ||
| Pubmed | Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo. | 3.28e-05 | 6 | 52 | 2 | 8084603 | |
| Pubmed | Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. | 3.28e-05 | 6 | 52 | 2 | 10636900 | |
| Pubmed | 3.43e-05 | 247 | 52 | 5 | 30713523 | ||
| Pubmed | 3.86e-05 | 859 | 52 | 8 | 31536960 | ||
| Pubmed | 4.42e-05 | 638 | 52 | 7 | 33239621 | ||
| Pubmed | 4.50e-05 | 878 | 52 | 8 | 37223481 | ||
| Pubmed | Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. | 4.58e-05 | 7 | 52 | 2 | 10837135 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 2158121 | ||
| Pubmed | Expression and distribution of Na, K-ATPase isoforms in the human uterus. | 4.58e-05 | 7 | 52 | 2 | 20065300 | |
| Pubmed | 4.64e-05 | 1440 | 52 | 10 | 30833792 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 4.83e-05 | 647 | 52 | 7 | 26618866 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 5.15e-05 | 269 | 52 | 5 | 30442662 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 5.15e-05 | 269 | 52 | 5 | 29511261 | |
| Pubmed | 5.20e-05 | 48 | 52 | 3 | 26590968 | ||
| Pubmed | 5.22e-05 | 655 | 52 | 7 | 35819319 | ||
| Pubmed | 5.32e-05 | 657 | 52 | 7 | 36180527 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 5.43e-05 | 272 | 52 | 5 | 25315684 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 19683723 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 2885848 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 23652595 | ||
| Pubmed | 6.53e-05 | 463 | 52 | 6 | 27503909 | ||
| Pubmed | 6.62e-05 | 52 | 52 | 3 | 20114047 | ||
| Pubmed | 7.34e-05 | 290 | 52 | 5 | 32929329 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 7.36e-05 | 942 | 52 | 8 | 31073040 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 15253893 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 20554749 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 8.20e-05 | 704 | 52 | 7 | 29955894 | |
| Pubmed | 8.58e-05 | 963 | 52 | 8 | 28671696 | ||
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 8.70e-05 | 155 | 52 | 4 | 22673621 | |
| Pubmed | 8.72e-05 | 1247 | 52 | 9 | 27684187 | ||
| Pubmed | 8.92e-05 | 156 | 52 | 4 | 37108203 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 9.27e-05 | 1257 | 52 | 9 | 37317656 | |
| Pubmed | Reproduction and immunity-driven natural selection in the human WFDC locus. | 9.79e-05 | 10 | 52 | 2 | 23292442 | |
| Pubmed | Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. | 9.79e-05 | 10 | 52 | 2 | 15062102 | |
| Pubmed | 9.84e-05 | 725 | 52 | 7 | 27025967 | ||
| Interaction | CRY2 interactions | 6.38e-07 | 194 | 52 | 7 | int:CRY2 | |
| Interaction | NFIX interactions | 2.52e-05 | 227 | 52 | 6 | int:NFIX | |
| Interaction | GAA interactions | 2.53e-05 | 135 | 52 | 5 | int:GAA | |
| Cytoband | 20q13.12 | 2.14e-03 | 60 | 52 | 2 | 20q13.12 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 6.34e-05 | 7 | 32 | 2 | 1208 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 4.56e-04 | 18 | 32 | 2 | 361 | |
| GeneFamily | Cyclins|F-boxes other | 2.16e-03 | 39 | 32 | 2 | 560 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP | 2.32e-05 | 172 | 52 | 5 | M8932 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 3.07e-05 | 305 | 52 | 6 | M40025 | |
| Coexpression | GSE27786_CD8_TCELL_VS_MONO_MAC_DN | 4.78e-05 | 200 | 52 | 5 | M4849 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_UP | 4.78e-05 | 200 | 52 | 5 | M5727 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP | 4.78e-05 | 200 | 52 | 5 | M6955 | |
| ToppCell | Severe-Treg|World / Disease group and Cell class | 2.89e-06 | 191 | 52 | 5 | 0a80b8c317e8da4d4722cfd13cdabc32b58021eb | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 3.12e-06 | 194 | 52 | 5 | e46963d5f156526342ebc0fb9e767d266e812c42 | |
| ToppCell | Severe-Treg|Severe / Disease group and Cell class | 3.12e-06 | 194 | 52 | 5 | 7d232d87262ec5f505901345da5113cabf821321 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-06 | 198 | 52 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 199 | 52 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.34e-05 | 124 | 52 | 4 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 147 | 52 | 4 | 9bc4185920b2b0f1fd5c6e2ec5583b9cd49c2efd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 147 | 52 | 4 | 9b0f87a6dd5224c2b06deafeae04a1b04e53eb75 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 157 | 52 | 4 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-05 | 161 | 52 | 4 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | Control-Treg|World / Disease group and Cell class | 3.74e-05 | 161 | 52 | 4 | ead9f5a491321f9e307f7c97e47a4ca124f59bb6 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 168 | 52 | 4 | 63437b3c3a66f953eaed600965ab193f9cc49da2 | |
| ToppCell | ASK452-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.65e-05 | 179 | 52 | 4 | c3cf49c069e66db16d2fce1de4c52a4c4fe7e832 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-05 | 180 | 52 | 4 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.42e-05 | 185 | 52 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 6.42e-05 | 185 | 52 | 4 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | normal_Lung-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 6.42e-05 | 185 | 52 | 4 | ea416362d3f06b4a0a7f08c2e5dbbc864f121555 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.83e-05 | 188 | 52 | 4 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 188 | 52 | 4 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 6.98e-05 | 189 | 52 | 4 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | (1)_T_cells-(1)_T_CD4_reg|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.12e-05 | 190 | 52 | 4 | ff42af092173c2d4472bb9a02f5a334c272e05a0 | |
| ToppCell | Control-Treg|Control / Disease group and Cell class | 7.41e-05 | 192 | 52 | 4 | 3a9a8ac2aa278adde848608f9bb92a002dbb9bcc | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.41e-05 | 192 | 52 | 4 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 7.56e-05 | 193 | 52 | 4 | bac302e69455aaaf1c18f3272bb213242664d747 | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 7.56e-05 | 193 | 52 | 4 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.72e-05 | 194 | 52 | 4 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.72e-05 | 194 | 52 | 4 | 0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.72e-05 | 194 | 52 | 4 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-05 | 195 | 52 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue | 8.03e-05 | 196 | 52 | 4 | 5755ca4abcae3717894bbf7cbd49bca0a3a03067 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 196 | 52 | 4 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 8.03e-05 | 196 | 52 | 4 | 181f3c1af565355b29f20ca6074147c313ca3477 | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 8.19e-05 | 197 | 52 | 4 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | (1)_T_cell-(15)_Treg|(1)_T_cell / shred on Cell_type and subtype | 8.19e-05 | 197 | 52 | 4 | 6e7723e8b977be35c60cc11ac7cfa4f71339441e | |
| ToppCell | Transverse-T_cell-Treg|T_cell / Region, Cell class and subclass | 8.19e-05 | 197 | 52 | 4 | b7a1637e4baadd657f6279f4aa96cd590c9cd8c9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-05 | 197 | 52 | 4 | 02cc9d39afefa5e5b6f5d93f9adc3a20050b70dd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.19e-05 | 197 | 52 | 4 | 54fb7197db3c0dc87a1114e1ab1d2bfafd564b35 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.35e-05 | 198 | 52 | 4 | 03423d6c614440b9c738f75ac3f5a6941719a279 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 8.35e-05 | 198 | 52 | 4 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.35e-05 | 198 | 52 | 4 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 198 | 52 | 4 | c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.35e-05 | 198 | 52 | 4 | d021d0edb6aba2f15c51a3ec4e08c7233d0c1962 | |
| ToppCell | Transverse-T_cell-gd_T|T_cell / Region, Cell class and subclass | 8.51e-05 | 199 | 52 | 4 | 8baea162803cea7d72dff5866a0eebfcf2e5dcd6 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.68e-05 | 200 | 52 | 4 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.68e-05 | 200 | 52 | 4 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 89 | 52 | 3 | e7d9498a1a3aa974fdd68b394c3eaff8e35c9727 | |
| ToppCell | BAL-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 6.45e-04 | 145 | 52 | 3 | 3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-04 | 145 | 52 | 3 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-04 | 145 | 52 | 3 | 2eebf2294c53f081d3b0169071388e477a195218 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.40e-04 | 152 | 52 | 3 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.40e-04 | 152 | 52 | 3 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 7.69e-04 | 154 | 52 | 3 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-04 | 154 | 52 | 3 | c6f1a0806d492b1f01cded2daffaf3f13422deb6 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 7.69e-04 | 154 | 52 | 3 | 835ef49d314ecbcbfd8d1041ba202a5eedcda0bd | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-04 | 154 | 52 | 3 | 9200e2f1783e54cbc5dfc3b485b57c761af74a46 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-04 | 154 | 52 | 3 | b16f3139ce50e70a6a2377b1da7d7877b4000ea1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-04 | 154 | 52 | 3 | 665885d8aca168513ab7a65f70d52181c821eb78 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-04 | 154 | 52 | 3 | 3c64111e2ca1bb04ddd1ecb19938a307778ff7eb | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-04 | 155 | 52 | 3 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-04 | 156 | 52 | 3 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.98e-04 | 156 | 52 | 3 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 157 | 52 | 3 | 264b22d0ffc43049161843bb55d2eccbf5fca575 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 157 | 52 | 3 | 67945d37027be62c880d3072afa7ca7e97c76c20 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 157 | 52 | 3 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 157 | 52 | 3 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.28e-04 | 158 | 52 | 3 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | 12a82230c01de552f12977634c304626e1cd6903 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | bd432ecd2524656804e7c2775250e27db7906b70 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-04 | 161 | 52 | 3 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-04 | 163 | 52 | 3 | bca9abd02ffb2a90c8386a59f5e25126ae7b6acd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.06e-04 | 163 | 52 | 3 | 39181c58387189a815e7b3eb29fbd1dd4ee24d0a | |
| ToppCell | facs-SCAT-Fat-24m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | 9fd2e495efb6c447cdc52efdb3b695cb2fa8b914 | |
| ToppCell | facs-SCAT-Fat-24m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | ade2f59bca0ab0c4856202f980464f3287bddd24 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Tnaive/CM_CD8|Lung / Manually curated celltypes from each tissue | 9.06e-04 | 163 | 52 | 3 | c8e4440d1a857e4da83002303940dd42b273c92e | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-04 | 163 | 52 | 3 | 11cc18f36604d9a5f4e7fb8626a8f0fb141da5e1 | |
| ToppCell | facs-SCAT-Fat-24m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | aaf5d96bab1957c7bde84c741c7f2fb86ef41e8b | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-04 | 164 | 52 | 3 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.38e-04 | 165 | 52 | 3 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.38e-04 | 165 | 52 | 3 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.38e-04 | 165 | 52 | 3 | 9f6f3a614ac614488e9f59cf2805467ff075ccca | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | 001a31aaa4ab4d5606b894faf6fcaad524405064 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | 31ed1290b4a977eabfc29674a5c593985bff6a74 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | c71ad3fc6a14507609d17756431d3deff9fda418 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-04 | 166 | 52 | 3 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | c02c2a68d61dbd7ed086d9b02cfcb1778b8a8656 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | 20c24a9d2eb67a20e5154d25656da14186034f02 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-04 | 167 | 52 | 3 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 9.71e-04 | 167 | 52 | 3 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.88e-04 | 168 | 52 | 3 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.88e-04 | 168 | 52 | 3 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.88e-04 | 168 | 52 | 3 | 55f328353119cbdc521c782ebb8d163876f4186d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.88e-04 | 168 | 52 | 3 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 169 | 52 | 3 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| Computational | Genes in the cancer module 286 | 1.58e-04 | 37 | 31 | 3 | MODULE_286 | |
| Drug | arabinosyladenine | BOC PIK3C2B NT5C3A ENTPD1 RBKS TAC3 IDH2 HARS1 ATP1A1 ATP1A3 MDH2 LDHC | 8.67e-08 | 762 | 51 | 12 | CID000000191 |
| Drug | bromfenacoum | RELN EEF2 ZC2HC1A MTHFD1 PLCG1 HARS1 ATP1A3 MDH2 HNRNPK SOD1 | 1.37e-06 | 644 | 51 | 10 | ctd:C013418 |
| Drug | NaCl | 3.97e-06 | 564 | 51 | 9 | CID000005234 | |
| Drug | NSC-7616 | 4.77e-06 | 50 | 51 | 4 | CID000000309 | |
| Drug | nsc25485 | 5.86e-06 | 312 | 51 | 7 | CID000004605 | |
| Drug | glutamate | CACNB1 RELN EEF2 MTHFD1 TRPM2 TAC3 PLCG1 IDH2 MDH2 LDHC SOD1 | 7.30e-06 | 962 | 51 | 11 | CID000000611 |
| Drug | AC1O54Y4 | 1.37e-05 | 65 | 51 | 4 | CID006452212 | |
| Drug | AC1L2506 | 1.47e-05 | 3 | 51 | 2 | CID000066271 | |
| Drug | pyridine | 1.52e-05 | 239 | 51 | 6 | CID000001049 | |
| Drug | T-2 Toxin | 1.54e-05 | 362 | 51 | 7 | ctd:D013605 | |
| Drug | hydroxymalonate | 1.82e-05 | 23 | 51 | 3 | CID000000044 | |
| Drug | AC1L1D5O | 2.28e-05 | 152 | 51 | 5 | CID000002204 | |
| Drug | carnitine | 2.73e-05 | 265 | 51 | 6 | CID000000085 | |
| Drug | magnesium | EEF2 MTHFD1 NT5C3A ENTPD1 RBKS IDH2 INPP5F ATP1A1 ATP1A3 MDH2 LDHC SOD1 | 2.74e-05 | 1325 | 51 | 12 | CID000000888 |
| Drug | genistein | CACNB1 EEF2 PIK3C2B MTHFD1 NT5C3A NCAPD2 PLCG1 ITGAV ABCC10 HNRNPK SOD1 | 2.94e-05 | 1117 | 51 | 11 | CID005280961 |
| Drug | fluorocitrate | 2.98e-05 | 27 | 51 | 3 | CID000107647 | |
| Drug | formate | 3.09e-05 | 271 | 51 | 6 | CID000000283 | |
| Drug | U46619 | 4.10e-05 | 285 | 51 | 6 | CID000005618 | |
| Drug | isofenphos | 4.55e-05 | 31 | 51 | 3 | CID000032872 | |
| Drug | 22,23-dihydrobufalin | 4.90e-05 | 5 | 51 | 2 | CID000195392 | |
| Drug | 3-acetylstrophanthin | 4.90e-05 | 5 | 51 | 2 | CID003082282 | |
| Drug | butanesulfonate | 4.90e-05 | 5 | 51 | 2 | CID000049935 | |
| Drug | thevetin A | 4.90e-05 | 5 | 51 | 2 | CID000441873 | |
| Drug | alphaNMN | 4.95e-05 | 90 | 51 | 4 | CID000000939 | |
| Drug | butandiol | 5.02e-05 | 32 | 51 | 3 | CID000165788 | |
| Drug | acetate | 5.14e-05 | 599 | 51 | 8 | CID000000175 | |
| Drug | aluminum | 5.67e-05 | 184 | 51 | 5 | CID000104727 | |
| Drug | S-allyl-L-cysteine | 7.18e-05 | 36 | 51 | 3 | CID000098280 | |
| Drug | N-methylhydantoin | 7.34e-05 | 6 | 51 | 2 | CID000069217 | |
| Drug | ETH157 | 7.34e-05 | 6 | 51 | 2 | CID000563154 | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 5638_UP | |
| Drug | chloride | 8.02e-05 | 1029 | 51 | 10 | CID000000312 | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 6275_UP | |
| Drug | lead nitrate | 9.90e-05 | 207 | 51 | 5 | ctd:C017461 | |
| Drug | Metazamide | 1.03e-04 | 7 | 51 | 2 | CID000026433 | |
| Drug | dihydrodigitoxigenin | 1.03e-04 | 7 | 51 | 2 | CID000107549 | |
| Drug | reduced diphosphopyridine nucleotide | 1.12e-04 | 342 | 51 | 6 | CID000000928 | |
| Drug | NSC20257 | 1.13e-04 | 213 | 51 | 5 | CID000001172 | |
| Drug | 3-phosphoglycerate | 1.24e-04 | 114 | 51 | 4 | CID000000724 | |
| Drug | alpha-methyl-D-mannoside | 1.33e-04 | 116 | 51 | 4 | CID000002108 | |
| Drug | adenine | 1.34e-04 | 510 | 51 | 7 | CID000000190 | |
| Drug | S-(1,2-dichlorovinyl)-L-homocysteine | 1.37e-04 | 8 | 51 | 2 | CID006437876 | |
| Drug | O-acetyltyrosine | 1.37e-04 | 8 | 51 | 2 | CID000226267 | |
| Drug | Ouabain | 1.47e-04 | 119 | 51 | 4 | ctd:D010042 | |
| Drug | NiCl2 | 1.47e-04 | 119 | 51 | 4 | CID000024385 | |
| Drug | hydroxyl radicals | BOC EEF2 MTHFD1 NT5C3A ENTPD1 PIPOX PLCG1 ATP1A1 ATP1A3 MDH2 SOD1 | 1.52e-04 | 1341 | 51 | 11 | CID000000961 |
| Drug | D-ribofuranose | 1.56e-04 | 228 | 51 | 5 | CID000000854 | |
| Drug | AC1L4B0X | 1.61e-04 | 122 | 51 | 4 | CID000153769 | |
| Drug | AC1MBZB6 | 1.75e-04 | 9 | 51 | 2 | CID002733620 | |
| Drug | 2-butenedioate | 1.76e-04 | 234 | 51 | 5 | CID000000723 | |
| Drug | AC1L9785 | 1.81e-04 | 49 | 51 | 3 | CID000439374 | |
| Drug | silver nitrate | 1.81e-04 | 49 | 51 | 3 | CID000024470 | |
| Drug | CO(2 | 1.93e-04 | 378 | 51 | 6 | CID000000280 | |
| Drug | mercury | 1.95e-04 | 542 | 51 | 7 | CID000023931 | |
| Drug | limonene | 2.17e-04 | 52 | 51 | 3 | ctd:C008281 | |
| Drug | nickel | 2.18e-04 | 552 | 51 | 7 | CID000000934 | |
| Drug | 8-bromoadenine | 2.19e-04 | 10 | 51 | 2 | CID000081457 | |
| Drug | mivazerol | 2.19e-04 | 10 | 51 | 2 | CID000060783 | |
| Drug | prostacyclin sodium salt | 2.39e-04 | 250 | 51 | 5 | CID000000159 | |
| Drug | H2O2 | 2.51e-04 | 1183 | 51 | 10 | CID000000784 | |
| Drug | DMTU | 2.56e-04 | 55 | 51 | 3 | CID002723631 | |
| Drug | K-Cl | 2.56e-04 | 567 | 51 | 7 | CID000004873 | |
| Drug | butylmalonate | 2.67e-04 | 11 | 51 | 2 | CID000010801 | |
| Drug | Calix[4]arene | 2.67e-04 | 11 | 51 | 2 | CID000562409 | |
| Drug | 26 d | 2.67e-04 | 11 | 51 | 2 | CID000008861 | |
| Drug | benzyl chloride | 2.67e-04 | 11 | 51 | 2 | CID000007503 | |
| Drug | ouabagenin | 2.67e-04 | 11 | 51 | 2 | CID000010497 | |
| Drug | NSC-312017 | 2.67e-04 | 11 | 51 | 2 | CID000432667 | |
| Drug | Xanthine | 2.84e-04 | 57 | 51 | 3 | ctd:D019820 | |
| Drug | AMP group | 2.91e-04 | 579 | 51 | 7 | CID000000224 | |
| Drug | dimethylformamide | 3.00e-04 | 58 | 51 | 3 | CID000006228 | |
| Drug | 2-isopropylmalate | 3.20e-04 | 12 | 51 | 2 | CID000000036 | |
| Drug | trifluoro-methyl | 3.31e-04 | 60 | 51 | 3 | CID000137518 | |
| Drug | alanine | 3.34e-04 | 269 | 51 | 5 | CID000000602 | |
| Drug | coenzyme 1 | 3.47e-04 | 596 | 51 | 7 | CID000000925 | |
| Drug | manganese | 3.47e-04 | 791 | 51 | 8 | CID000023930 | |
| Disease | Bipolar Disorder | 1.51e-05 | 477 | 50 | 7 | C0005586 | |
| Disease | Anterior Horn Cell Disease | 1.68e-05 | 4 | 50 | 2 | C0154681 | |
| Disease | Motor Neuron Disease, Upper | 1.68e-05 | 4 | 50 | 2 | C0521659 | |
| Disease | Motor Neuron Disease, Secondary | 1.68e-05 | 4 | 50 | 2 | C0543858 | |
| Disease | Motor Neuron Disease | 1.68e-05 | 4 | 50 | 2 | C0085084 | |
| Disease | Familial Motor Neuron Disease | 1.68e-05 | 4 | 50 | 2 | C0270763 | |
| Disease | Motor Neuron Disease, Lower | 1.68e-05 | 4 | 50 | 2 | C0270764 | |
| Disease | Lateral Sclerosis | 2.80e-05 | 5 | 50 | 2 | C0154682 | |
| Disease | Down syndrome (is_implicated_in) | 4.20e-05 | 6 | 50 | 2 | DOID:14250 (is_implicated_in) | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 5.88e-05 | 7 | 50 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Acute Cerebrovascular Accidents | 1.07e-04 | 54 | 50 | 3 | C0751956 | |
| Disease | colorectal cancer (is_marker_for) | 1.47e-04 | 157 | 50 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Cerebrovascular accident | 1.61e-04 | 62 | 50 | 3 | C0038454 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.84e-04 | 12 | 50 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 3.43e-04 | 80 | 50 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (is_marker_for) | 4.10e-04 | 85 | 50 | 3 | DOID:3910 (is_marker_for) | |
| Disease | Degenerative polyarthritis | 5.34e-04 | 93 | 50 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 5.34e-04 | 93 | 50 | 3 | C0086743 | |
| Disease | Down syndrome (is_marker_for) | 6.36e-04 | 22 | 50 | 2 | DOID:14250 (is_marker_for) | |
| Disease | calcium measurement | 6.51e-04 | 628 | 50 | 6 | EFO_0004838 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 7.58e-04 | 24 | 50 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.43e-04 | 447 | 50 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | Alzheimer's disease (is_marker_for) | 9.45e-04 | 257 | 50 | 4 | DOID:10652 (is_marker_for) | |
| Disease | Ventricular Dysfunction, Left | 1.19e-03 | 30 | 50 | 2 | C0242698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRVEEIICGLIKGGA | 66 | Q9H0P0 | |
| IGRLVKEGCEVGFIP | 146 | Q02641 | |
| RGIKGVVTDEQGIPI | 906 | Q8IUX7 | |
| VPVEIVGQGKLGEVA | 151 | Q9UK96 | |
| KRGCQVVIITLGAEG | 226 | Q9H477 | |
| VTFCVQPGEKLGIVG | 1266 | Q5T3U5 | |
| GIVVPCKEGQLRVGE | 11 | Q8TEW8 | |
| GPDGKECVVKEVVPG | 246 | Q8IY17 | |
| PGLIKVEQARCGEVA | 246 | Q5JYT7 | |
| KGCDVVVIPAGVPRK | 91 | P40926 | |
| VVGDLVEVKGGDRIP | 186 | P05023 | |
| GQGLVPVVECVVDGQ | 296 | P0C7T5 | |
| KCQQEGLVPEGGVEE | 91 | Q9UK22 | |
| QIEAKFIGIIECGGI | 171 | Q8N4E4 | |
| IPCVLGRNGVSDVVK | 291 | P07864 | |
| GVVHQVEECRVKGPG | 76 | P49961 | |
| VIGGEIVKPEQGCGV | 1086 | P78509 | |
| VDPLGENIRVIFKCG | 1071 | O00750 | |
| GKVIEPGCVRVVRGE | 301 | O60884 | |
| NILGGTVFREPIICK | 141 | P48735 | |
| DVEGKIRQIIPPGFC | 106 | O14929 | |
| VQKPGGTVILGCVVE | 46 | Q9BWV1 | |
| TQPGIVEGGQVLKCD | 76 | P06756 | |
| VQVGGDIVIGCKPNA | 421 | Q9UQ52 | |
| VVGDLVEIKGGDRVP | 176 | P13637 | |
| IEDVPCGNIVGLVGV | 461 | P13639 | |
| GVLKVGQETEVRPGI | 286 | Q2VIR3 | |
| NPICLGLVEGVIGKI | 41 | Q9Y2H2 | |
| KVPCVGLSIGVERIF | 376 | P12081 | |
| PRCGEVESVGKVVQE | 846 | O94829 | |
| GCLELIKETGVPIAG | 151 | P11586 | |
| VIIDIPEGGNGKREC | 551 | Q5HYK7 | |
| VLPQRCVGLEKGTLV | 91 | Q5T9Z0 | |
| RVVLIGGKPDRVVEC | 191 | P61978 | |
| GEVLGVIGDCPELVQ | 1306 | Q7Z3K3 | |
| GIKIPEGCVRRVLQE | 1206 | Q9Y2G9 | |
| VCVLKGDGPVQGIIN | 6 | P00441 | |
| GEIVREIGQKCPQEL | 276 | Q15021 | |
| RGGDCPKVLVGLCIV | 166 | Q8IUB2 | |
| VEGVKEGIEKAGVCP | 21 | Q8WWY7 | |
| IKIPIVCVVLEGGPG | 321 | O94759 | |
| EQNQGPRKIGVCIIV | 31 | Q9BTD3 | |
| VLVNGTKERDVVCGP | 146 | Q07011 | |
| PKNGRGIVCPFVEIE | 1101 | P19174 | |
| VGRIIGQKLGCCVID | 71 | Q8IYQ7 | |
| ENGGVVQVGELLPCK | 6 | Q96GY0 | |
| IIPQKAIVGEIGHGC | 71 | Q96JF6 | |
| GGIVRDGEKVVEINP | 166 | Q9P0Z9 | |
| AVCKEPQEEVVPGGG | 21 | Q9UHF0 | |
| LCKEEGGGQVELIPN | 2606 | O95071 | |
| CEVLGNDIGLPKRVV | 2976 | Q15911 | |
| LREVCPVQEIDGKAG | 176 | Q3MJ62 |